
    
      The purpose of this study is to determine if a 5-day regimen of favipiravir reduces the time
      to alleviation of influenza symptoms, resolution of fever, and viral shedding, in subjects
      with uncomplicated influenza compared to no treatment (e.g. placebo).
    
  